| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1240742
[patent_doc_number] => 06682728
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-01-27
[patent_title] => 'Efficient and selective adenoviral-mediated gene transfer into vascular neointima'
[patent_app_type] => B1
[patent_app_number] => 08/136113
[patent_app_country] => US
[patent_app_date] => 1993-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6919
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/682/06682728.pdf
[firstpage_image] =>[orig_patent_app_number] => 08136113
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/136113 | Efficient and selective adenoviral-mediated gene transfer into vascular neointima | Oct 12, 1993 | Issued |
| 08/129123 | ANTISENSE OLIGONUCLEOTIDES TO C-KIT PROTO-ONCOGENE AND USES THEREOF | Oct 6, 1993 | Abandoned |
Array
(
[id] => 3690558
[patent_doc_number] => 05604131
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-02-18
[patent_title] => 'cDNA-genomic DNA hybrid sequence encoding APP770 containing a genomic DNA insert of the KI and OX-2 regions'
[patent_app_type] => 1
[patent_app_number] => 8/123702
[patent_app_country] => US
[patent_app_date] => 1993-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 38
[patent_no_of_words] => 13085
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/604/05604131.pdf
[firstpage_image] =>[orig_patent_app_number] => 123702
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/123702 | cDNA-genomic DNA hybrid sequence encoding APP770 containing a genomic DNA insert of the KI and OX-2 regions | Sep 16, 1993 | Issued |
Array
(
[id] => 3705483
[patent_doc_number] => 05675058
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-07
[patent_title] => 'Bioassay for thrombogenesis and rabbit model'
[patent_app_type] => 1
[patent_app_number] => 8/116845
[patent_app_country] => US
[patent_app_date] => 1993-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3917
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/675/05675058.pdf
[firstpage_image] =>[orig_patent_app_number] => 116845
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/116845 | Bioassay for thrombogenesis and rabbit model | Sep 6, 1993 | Issued |
| 08/116983 | METHODS OF SUPPRESSING AUTOIMMUNE RESPONSE | Sep 2, 1993 | Abandoned |
| 08/114910 | METHODS AND COMPOSITIONS FOR BINDING TAU PROTEIN AND INHIBITING NEUROFIBRILLARY TANGLE FORMATION | Aug 30, 1993 | Abandoned |
Array
(
[id] => 3634278
[patent_doc_number] => 05631236
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-05-20
[patent_title] => 'Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk'
[patent_app_type] => 1
[patent_app_number] => 8/112745
[patent_app_country] => US
[patent_app_date] => 1993-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 3476
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/631/05631236.pdf
[firstpage_image] =>[orig_patent_app_number] => 112745
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/112745 | Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk | Aug 25, 1993 | Issued |
Array
(
[id] => 3999636
[patent_doc_number] => 05922854
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-13
[patent_title] => 'Purifying Human Hemogloblin from transgenic pig red cells and plasmids containing pig globin nucleic acids'
[patent_app_type] => 1
[patent_app_number] => 8/105989
[patent_app_country] => US
[patent_app_date] => 1993-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 75
[patent_figures_cnt] => 77
[patent_no_of_words] => 17628
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/922/05922854.pdf
[firstpage_image] =>[orig_patent_app_number] => 105989
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/105989 | Purifying Human Hemogloblin from transgenic pig red cells and plasmids containing pig globin nucleic acids | Aug 10, 1993 | Issued |
| 08/111581 | MUTANT MOUSE LACKING CD4 SURFACE MARKER | Aug 3, 1993 | Abandoned |
| 08/096944 | TRANSGENIC ANIMAL MODEL FOR COGNITIVE DISORDERS | Jul 21, 1993 | Pending |
Array
(
[id] => 1579706
[patent_doc_number] => 06448469
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-10
[patent_title] => 'Production of membrane proteins in the milk of transgenic nonhuman mammals'
[patent_app_type] => B1
[patent_app_number] => 08/088416
[patent_app_country] => US
[patent_app_date] => 1993-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 4799
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/448/06448469.pdf
[firstpage_image] =>[orig_patent_app_number] => 08088416
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/088416 | Production of membrane proteins in the milk of transgenic nonhuman mammals | Jul 6, 1993 | Issued |
Array
(
[id] => 3725074
[patent_doc_number] => 05651964
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-29
[patent_title] => 'Methods for the suppression of neu mediated tumors by the adenoviral EIA gene'
[patent_app_type] => 1
[patent_app_number] => 8/070410
[patent_app_country] => US
[patent_app_date] => 1993-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 36
[patent_no_of_words] => 11697
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/651/05651964.pdf
[firstpage_image] =>[orig_patent_app_number] => 070410
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/070410 | Methods for the suppression of neu mediated tumors by the adenoviral EIA gene | Jun 3, 1993 | Issued |
Array
(
[id] => 3522510
[patent_doc_number] => 05530177
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-06-25
[patent_title] => 'Transgenic mice producing bovine .alpha.-lactalbumin in their milk'
[patent_app_type] => 1
[patent_app_number] => 8/071601
[patent_app_country] => US
[patent_app_date] => 1993-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 7540
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/530/05530177.pdf
[firstpage_image] =>[orig_patent_app_number] => 071601
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/071601 | Transgenic mice producing bovine .alpha.-lactalbumin in their milk | Jun 3, 1993 | Issued |
| 08/067296 | GENE THERAPY FOR CYSTIC FIBROSIS | May 24, 1993 | Pending |
| 08/050559 | NEURAL THREAD PROTEIN GENE EXPRESSION AND DETECTION OF ALZHEIMER'S DISEASE | Apr 19, 1993 | Pending |
Array
(
[id] => 3110257
[patent_doc_number] => 05409700
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-04-25
[patent_title] => 'Pharmaceutical compositions comprising modified and unmodified plasminogen activators'
[patent_app_type] => 1
[patent_app_number] => 8/044563
[patent_app_country] => US
[patent_app_date] => 1993-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 34
[patent_no_of_words] => 26600
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/409/05409700.pdf
[firstpage_image] =>[orig_patent_app_number] => 044563
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/044563 | Pharmaceutical compositions comprising modified and unmodified plasminogen activators | Apr 6, 1993 | Issued |
Array
(
[id] => 3700557
[patent_doc_number] => 05674730
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-07
[patent_title] => 'Eukaryotic cells comprising a DNA sequence encoding a bacterial-viral chimeric transactivator protein'
[patent_app_type] => 1
[patent_app_number] => 8/041297
[patent_app_country] => US
[patent_app_date] => 1993-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 15
[patent_no_of_words] => 14298
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/674/05674730.pdf
[firstpage_image] =>[orig_patent_app_number] => 041297
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/041297 | Eukaryotic cells comprising a DNA sequence encoding a bacterial-viral chimeric transactivator protein | Mar 29, 1993 | Issued |
| 08/038085 | CELL LINEAGES EXPRESSING A BIOLOGICAL ACTIVE IX FACTOR | Mar 28, 1993 | Pending |
| 08/036988 | TRANSGENIC ANIMAL AS MODEL FOR DISEASE | Mar 24, 1993 | Pending |
Array
(
[id] => 3416318
[patent_doc_number] => 05453366
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-09-26
[patent_title] => 'Method of cloning bovine embryos'
[patent_app_type] => 1
[patent_app_number] => 8/031815
[patent_app_country] => US
[patent_app_date] => 1993-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6977
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/453/05453366.pdf
[firstpage_image] =>[orig_patent_app_number] => 031815
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/031815 | Method of cloning bovine embryos | Mar 14, 1993 | Issued |